Development of Macrocyclic PRMT5–Adaptor Protein Interaction Inhibitors-Reference-Cited by-同舟云学术

Development of Macrocyclic PRMT5–Adaptor Protein Interaction Inhibitors

Published:2022-11-15 Issue:22 Volume:65 Page:15300-15311
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Krzyzanowski Adrian¹²,Esser Lea Marie³,Willaume Anthony⁴,Prudent Renaud⁴,Peter Christoph³^ORCID,‘t Hart Peter⁵,Waldmann Herbert¹²^ORCID

Affiliation:

1. Department of Chemical Biology, Max Planck Institute of Molecular Physiology, Otto-Hahn-Straße 11, 44227 Dortmund, Germany

2. Faculty of Chemistry, Chemical Biology, Technical University Dortmund, Otto-Hahn-Straße 6, 44221 Dortmund, Germany

3. Institute of Molecular Medicine I, Medical Faculty and University Hospital, Heinrich Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany

4. Edelris, Bioserra 1, 60 Avenue Rockefeller, 69008 Lyon, France

5. Chemical Genomics Centre of the Max Planck Society, Max Planck Institute of Molecular Physiology, Otto-Hahn-Straße 11, 44227 Dortmund, Germany

Funder

Verband der Chemischen Industrie

Aventis Foundation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c01273

Reference38 articles.

1. The Structure and Functions of PRMT5 in Human Diseases

2. Cellular pathways influenced by protein arginine methylation: Implications for cancer

3. Protein Arginine Methyltransferase 5 (PRMT5) as an Anticancer Target and Its Inhibitor Discovery

4. Protein arginine methylation: from enigmatic functions to therapeutic targeting

5. Biochemical Investigation of the Interaction of pICln, RioK1 and COPR5 with the PRMT5–MEP50 Complex

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bipyridine Derivatives as NOP2/Sun RNA Methyltransferase 3 Inhibitors for the Treatment of Colorectal Cancer;Journal of Medicinal Chemistry;2024-07-26

2. Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2low Adult T-Cell Leukemia/Lymphoma;International Journal of Molecular Sciences;2024-02-29

3. RECENT ADVANCES IN TARGETING THE PRMT5/MTA COMPLEX;Medicinal Chemistry Reviews;2023-11-16

4. The RioK1 network determines p53 activity at multiple levels;Cell Death Discovery;2023-11-07

5. On-Resin Photochemical Decarboxylative Arylation of Peptides;Organic Letters;2023-10-11